Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt
Authors:
- Victoria HoskinVHVictoria Hoskin
- Esther CarefootECEsther Carefoot
- Bruce ElliottBEBruce Elliott
- Leda RaptisLeda Raptis
Open Access
- 13 November 2015
- journal article
- review article
- Published by Walter de Gruyter GmbH in BioMolecular Concepts
- Vol. 6 (5-6) , 383-399
Abstract
Both cell-cell and cell-matrix adhesion are important for epithelial cell differentiation and function. Classical cadherins mediate cell to cell interactions and are potent activators of the signal transducer and activator of transcription (Stat3), thereby offering survival signaling. While the epithelial (E)-cadherin is required for cells to remain tightly associated within differentiated epithelial tissues, cadherin-11 promotes invasion and metastasis, preferentially to the bone. Cell adhesion to the extracellular matrix is mediated through the integrin receptors that bind to the focal adhesion kinase (FAK)/Src complex, thus activating downstream effectors such as Ras/Erk1/2 and PI3k/Akt, but not Stat3. Therefore, at high densities of cultured cells or in epithelial tissues, co-ordinate activation of the complementary cadherin/Stat3 and integrin/FAK pathways can greatly enhance survival and growth of tumor cells. In neoplastically transformed cells on the other hand, a variety of oncogenes including activated Src or receptor tyrosine kinases, activate both pathways. Still, most single-agent therapies directed against these signaling pathways have proven disappointing in the clinic. Combined targeting of the Src/FAK and Stat3 pathways with inhibitory drugs would be expected to have greater efficacy in inhibiting tumor cell survival, and enhancing sensitivity to conventional cytotoxic drugs for treatment of metastatic disease.Keywords
This publication has 158 references indexed in Scilit:
- Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein KinaseMolecular Cell, 2012
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 StudyClinical Cancer Research, 2011
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceNature Medicine, 2010
- Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrinOncogene, 2009
- Cadherins and cancer: how does cadherin dysfunction promote tumor progression?Oncogene, 2008
- Modulation of E-Cadherin Monomer Folding by Cooperative Binding of Calcium IonsBiochemistry, 2008
- The role of focal-adhesion kinase in cancer — a new therapeutic opportunityNature Reviews Cancer, 2005
- Focal adhesion kinase: in command and control of cell motilityNature Reviews Molecular Cell Biology, 2005
- Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasisOncogene, 2004
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004